Avi Oler | SVP of Corporate Development and General Counsel |
Steve Fruchtman | President and CEO |
Mark Guerin | CFO |
Ric Woodman | Chief Medical Officer |
Rajwanth Veluswamy | Assistant Professor, Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai |
Joe Pantginis | H.C. Wainwright |
Ahu Demir | Noble Capital Markets |
Yale Jen | Laidlaw & Company |
Ladies and gentlemen, thank you for standing by. Welcome to the Onconova Therapeutics Third Quarter Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode.
Following management's prepared remarks, we will hold the question-and-answer session. [Operator Instructions] As a reminder, this conference call is being recorded today November 12, 2020.